Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1972 1
1983 1
1986 2
1987 16
1988 64
1989 64
1990 71
1991 49
1992 62
1993 93
1994 70
1995 73
1996 71
1997 96
1998 83
1999 103
2000 115
2001 104
2002 109
2003 121
2004 135
2005 154
2006 151
2007 154
2008 140
2009 159
2010 186
2011 213
2012 202
2013 262
2014 428
2015 497
2016 555
2017 578
2018 551
2019 557
2020 1198
2021 1328
2022 601
Text availability
Article attribute
Article type
Publication date

Search Results

8,388 results
Results by year
Filters applied: . Clear all
Page 1
Breakthrough SARS-CoV-2 infections after vaccination: a critical review.
Mohseni Afshar Z, Barary M, Hosseinzadeh R, Alijanpour A, Hosseinzadeh D, Ebrahimpour S, Nazary K, Sio TT, Sullman MJM, Carson-Chahhoud K, Babazadeh A. Mohseni Afshar Z, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2051412. doi: 10.1080/21645515.2022.2051412. Epub 2022 Mar 18. Hum Vaccin Immunother. 2022. PMID: 35302905 Free PMC article. Review.
Contemporary National Trends and Outcomes of Pulmonary Embolism in the United States.
Sedhom R, Megaly M, Elbadawi A, Elgendy IY, Witzke CF, Kalra S, George JC, Omer M, Banerjee S, Jaber WA, Shishehbor MH. Sedhom R, et al. Am J Cardiol. 2022 Aug 1;176:132-138. doi: 10.1016/j.amjcard.2022.03.060. Epub 2022 May 28. Am J Cardiol. 2022. PMID: 35637010
Contemporary data on the national trends in pulmonary embolism (PE) admissions and outcomes are scarce. We aimed to analyze trends in mortality and different treatment methods in acute PE. ...In conclusion, this study showed that the rate of in-hospital mortality in high-r …
Contemporary data on the national trends in pulmonary embolism (PE) admissions and outcomes are scarce. We aimed to analyze trends in …
Autopsy study of fatal invasive pulmonary aspergillosis: Often undiagnosed premortem.
Mudrakola HV, Tandon YK, DeMartino E, Tosh PK, Yi ES, Ryu JH. Mudrakola HV, et al. Respir Med. 2022 Aug;199:106882. doi: 10.1016/j.rmed.2022.106882. Epub 2022 May 20. Respir Med. 2022. PMID: 35633606 Review.
We reviewed cases of fatal IA confirmed at autopsy (N = 67) between 1999 and 2019 at a tertiary academic hospital. At autopsy, pulmonary involvement was present in 97% of cases--46% were limited to the lungs and 51% had concomitant extrapulmonary involvement. Immunosuppres …
We reviewed cases of fatal IA confirmed at autopsy (N = 67) between 1999 and 2019 at a tertiary academic hospital. At autopsy, pulmonary
Evaluation of interstitial lung disease: An algorithmic review using ILD-RADS.
Pagano AM, Vu T, Berkowitz EA, Little BP, Chung M, Bernheim A. Pagano AM, et al. Clin Imaging. 2022 Aug;88:45-52. doi: 10.1016/j.clinimag.2022.04.019. Epub 2022 May 4. Clin Imaging. 2022. PMID: 35623119 Review.
Interstitial lung diseases (ILDs) may present a diagnostic dilemma due to their many classifications and overlapping imaging findings. In this review, we present an algorithmic approach for assessing ILDs based on identifying and understanding key imaging features t …
Interstitial lung diseases (ILDs) may present a diagnostic dilemma due to their many classifications and overlapping imaging f …
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial.
Hoppe BS, Nichols RC, Flampouri S, Pankuch M, Morris CG, Pham DC, Mohindra P, Hartsell WF, Mohammed N, Chon BH, Kestin LL, Simone CB 2nd. Hoppe BS, et al. Int J Radiat Oncol Biol Phys. 2022 Jul 15;113(4):732-741. doi: 10.1016/j.ijrobp.2022.03.005. Epub 2022 Mar 17. Int J Radiat Oncol Biol Phys. 2022. PMID: 35306151 Free article. Clinical Trial.
PURPOSE: Hypofractionated radiation therapy has been safely implemented in the treatment of early-stage non-small cell lung cancer (NSCLC) but not locally advanced NSCLC owing to prohibitive toxicities with photon therapy. ...No acute grade 3 esophagitis occurred. Only 14% …
PURPOSE: Hypofractionated radiation therapy has been safely implemented in the treatment of early-stage non-small cell lung cancer (N …
8,388 results